- Report
- December 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- October 2024
- 200 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- October 2023
- 216 Pages
Global
From €4505EUR$4,950USD£3,827GBP
- Report
- February 2024
- 255 Pages
Global
From €4505EUR$4,950USD£3,827GBP
- Report
- March 2021
- 216 Pages
Global
From €1251EUR$1,375USD£1,063GBP
€2503EUR$2,750USD£2,126GBP
- Report
- September 2023
- 140 Pages
Global
From €3276EUR$3,599USD£2,782GBP
- Report
- November 2022
- 303 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- April 2022
- 325 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Report
- February 2025
- 86 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- November 2021
- 1032 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Book
- April 2015
- 264 Pages
- Book
- November 2011
Global

Biomarker assays are laboratory tests used to measure the presence and/or concentration of biomarkers in biological samples. Biomarkers are molecules, genes, or other characteristics that can be used to measure the presence or progression of a disease, or to measure the effectiveness of a treatment. Biomarker assays are used in a variety of medical and research applications, including diagnostics, drug development, and personalized medicine.
The biomarker assay market is a rapidly growing segment of the healthcare industry, driven by advances in technology and the increasing demand for personalized medicine. The market is expected to grow due to the increasing prevalence of chronic diseases, the growing demand for early diagnosis, and the increasing use of biomarkers in drug development.
Some of the major companies in the biomarker assay market include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Becton Dickinson, and Roche Diagnostics. Show Less Read more